Jove
Visualize
Contact Us

Related Concept Videos

Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

849
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
849
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

22.0K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.0K
MicroRNAs01:22

MicroRNAs

21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
Master Transcription Regulators02:23

Master Transcription Regulators

6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Regulated mRNA Transport02:22

Regulated mRNA Transport

6.2K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.2K
Transcription Factors02:16

Transcription Factors

75.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latency-Associated Peptide Rapidly Upregulates Neuraminidase 3 in a Profibrotic Translation-Based Positive Feedback Loop.

Cells·2026
Same author

Phosphoproteomic Profiling Reveals Overlapping and Distinct Signaling Pathways in <i>Dictyostelium discoideum</i> in Response to Two Different Chemorepellents.

Cells·2026
Same author

Pharmacological inhibition of host pathways enhances macrophage killing of intracellular bacterial pathogens.

Microbiology spectrum·2025
Same author

Phosphoproteomic Profiling Reveals Overlapping and Distinct Signaling Pathways in <i>Dictyostelium discoideum</i> in Response to two different chemorepellents.

bioRxiv : the preprint server for biology·2025
Same author

Two endogenous <i>Dictyostelium discoideum</i> chemorepellents use different mechanisms to induce repulsion.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Pharmacological inhibition of host pathways enhances macrophage killing of intracellular bacterial pathogens.

bioRxiv : the preprint server for biology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 14, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:02

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

88

Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications.

Sumeen Kaur Gill1, Richard H Gomer1

  • 1Department of Biology, Texas A&M University, College Station, TX 77843, USA.

Cells
|April 11, 2025
PubMed
Summary

Idiopathic pulmonary fibrosis (IPF) involves excessive scarring. This review explores how microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA modifications impact IPF, suggesting therapeutic potential by correcting dysregulated translational regulators.

Keywords:
alternative polyadenylationepigenetic modificationsidiopathic pulmonary fibrosislong non-coding RNAmicroRNAtranslation

More Related Videos

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.1K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.3K

Related Experiment Videos

Last Updated: May 14, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:02

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

88
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.1K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.3K

Area of Science:

  • * Molecular Biology
  • * Pulmonary Medicine
  • * Genetics

Background:

  • * Fibrosing disorders, such as idiopathic pulmonary fibrosis (IPF), are characterized by progressive, irreversible scarring and extracellular matrix accumulation, often leading to poor prognoses.
  • * Gene expression is critically controlled by translational regulation, and its dysregulation is implicated in IPF pathogenesis.
  • * Understanding translational regulators is key to developing effective IPF therapies.

Purpose of the Study:

  • * To review the current literature on translational regulators in IPF.
  • * To focus on the roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA transcript modifications (alternative polyadenylation, chemical modification) in IPF.
  • * To explore the potential of targeting these regulators for IPF therapeutics.

Main Methods:

  • * Comprehensive literature review of translational regulation in IPF.
  • * Analysis of the roles of specific translational regulators, including miRNAs and lncRNAs.
  • * Examination of RNA transcript modifications such as alternative polyadenylation and chemical modifications.

Main Results:

  • * Translational regulators significantly influence fibrosis, with some promoting and others inhibiting the process.
  • * In IPF, profibrotic regulators are often upregulated, while antifibrotic regulators are downregulated.
  • * Specific miRNAs, lncRNAs, and RNA modifications are identified as key players in IPF-associated fibrosis.

Conclusions:

  • * Dysregulated translational regulators are central to IPF pathogenesis.
  • * Targeting aberrant profibrotic and antifibrotic regulators presents a promising therapeutic strategy for IPF.
  • * Further research into these regulators could unlock novel treatments for fibrosing lung diseases.